BridgeMD
New treatment option for Multiple System Atrophy
Official title Medical Decision Making in Multiple System Atrophy
ClinicalTrials.gov ID: NCT06072105
What this study is testing
- What it's testing
- The goal of this clinical study is to evaluate the effects of a personalized symptomatic treatment plan integrated with monthly telemedicine and mobile palliative care interventions on a population of individuals diagnosed with Multiple System Atrophy (MSA) and their informal caregivers. The aim is to improve the quality of life of MSA patients and their caregivers, as well as provide them with better support during the disease progression.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 and older
You may be able to join if
- For individuals with MSA:
- Age ≥30 years at the time of consent;
- Diagnosed with clinically probable or clinically established MSA according to the current MDS MSA criteria (1);
- Life-expectancy of at least 24 months as assessed by the investigator at the time of consent;
- Understands and agrees to comply with the study procedures and provides written informed consent (Note: a legal representative may NOT provide...
You likely can't join if
- For individuals with MSA
- Participation in an treatment clinical study at screening and throughout the study that would interfere with the MeDeMSA Care personalized treatment...
- Charlson comorbidity index \>4 at the time of consent;
- Other major underlying medical conditions that may confound interpretation of study results as assessed by the investigator.
See the full eligibility criteria
- For individuals with MSA:
- Age ≥30 years at the time of consent;
- Diagnosed with clinically probable or clinically established MSA according to the current MDS MSA criteria (1);
- Life-expectancy of at least 24 months as assessed by the investigator at the time of consent;
- Understands and agrees to comply with the study procedures and provides written informed consent (Note: a legal representative may NOT provide consent on behalf of the subject);
- Signed and dated informed consent document;
- Fluency in German;
- If not able to walk or stand without assistance/support at the time of consent, the participant lives in Tyrol or in another Austrian Region with available mobile palliative care. For informal caregivers:
- Informal caregiver (i.e. person not receiving payment for his/her caregiving) of an individual with MSA recruited in the present study;
- Life-expectancy of at least 24 months as assessed by the investigator at the time of consent;
- Age≥ 18 years at the time of consent;
- Understands and agrees to provide information as outlined in the study protocol and to engage in semi-structured online interviews;
- Provides signed and dated written informed consent;
- Full legal capacity;
- Fluency in German.
- For individuals with MSA
- Participation in an treatment clinical study at screening and throughout the study that would interfere with the MeDeMSA Care personalized treatment plan or would not permit telemedicine and mobile palliative care...
- Charlson comorbidity index \>4 at the time of consent;
- Other major underlying medical conditions that may confound interpretation of study results as assessed by the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Innsbruck, Austria, Austria
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Innsbruck, Austria, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.